Acromegaly is a hormonal disorder in which the body produces too much growth hormone, causing bones, organs, and soft tissues to enlarge gradually over years. It affects roughly 127 people per million, with about 4.6 new cases per million diagnosed each year. Because the changes happen slowly, most people live with symptoms for more than five years before getting a diagnosis, with the average delay sitting at 5.5 years from the first noticeable changes.
How Excess Growth Hormone Causes the Problem
Growth hormone is produced by the pituitary gland, a pea-sized structure at the base of the brain. In a healthy body, growth hormone travels to the liver and other tissues, where it triggers the production of a second hormone called IGF-1. About 80% of circulating IGF-1 comes from the liver. IGF-1 is what actually drives cell growth, bone remodeling, and muscle development.
In acromegaly, the pituitary gland pumps out far more growth hormone than the body needs. Normally, built-in feedback mechanisms dial down the signal when levels get too high. But in acromegaly, those braking systems get overwhelmed. The result is persistently elevated IGF-1, which pushes tissues throughout the body into a state of continuous, abnormal growth.
What Causes the Hormone Excess
In the vast majority of cases, a noncancerous tumor (adenoma) on the pituitary gland is responsible. These tumors are classified by size: microadenomas are smaller than 10 mm, macroadenomas are 10 mm or larger, and giant adenomas exceed 40 mm. Many of these tumors carry a specific genetic mutation (in a gene called GNAS) that locks the growth-hormone-producing cells into an “always on” state. Rarely, tumors in other parts of the body produce hormones that stimulate the pituitary indirectly, but this accounts for a small fraction of cases.
Recognizable Physical Changes
The hallmark of acromegaly is gradual enlargement of the hands, feet, and face. People often notice their rings no longer fit or they need a larger shoe size. Facial changes include a more prominent brow, a jutting lower jaw, a wider nose, and thicker lips. The jaw can grow enough to create noticeable spacing between the teeth. These changes develop so slowly that friends and family may not notice them for years, which is one reason the diagnostic delay is so long.
Other common symptoms include joint pain, carpal tunnel syndrome, excessive sweating, headaches, and vision changes caused by the pituitary tumor pressing on nearby nerves. Skin often becomes thicker and oilier. The voice may deepen as soft tissues in the throat enlarge.
Serious Health Complications
Left untreated, acromegaly doesn’t just change appearance. It strains nearly every organ system, and cardiovascular and respiratory problems are the leading causes of death in people with the condition.
The heart is especially vulnerable. Chronic growth hormone excess leads to thickening of the heart muscle, impaired pumping ability, high blood pressure, abnormal heart rhythms, and valve disease. Blood vessel linings also deteriorate, raising the risk of vascular problems.
Respiratory complications tend to appear early. Sleep apnea is particularly common because soft tissue growth in the airway narrows the breathing passages. Some patients develop respiratory insufficiency even before other symptoms become obvious.
Metabolic effects include disrupted blood sugar regulation and abnormal cholesterol levels. Diabetes develops in a meaningful proportion of patients because excess growth hormone interferes with the way the body responds to insulin.
How Acromegaly Is Diagnosed
Diagnosis relies primarily on blood tests. The key marker is IGF-1: if your level is more than 1.3 times the upper limit of normal for your age, that confirms the diagnosis in someone with typical signs and symptoms. IGF-1 is more reliable than measuring growth hormone directly because growth hormone fluctuates throughout the day, while IGF-1 stays relatively stable.
In borderline cases where IGF-1 alone doesn’t give a clear answer, a glucose suppression test can help. You drink a glucose solution, and growth hormone levels are measured over the next two hours. In a healthy person, growth hormone drops sharply after a sugar load. In acromegaly, it stays elevated. The threshold depends on body weight: lower cutoffs apply for people with a normal BMI compared to those with a higher BMI. However, experts now recommend reserving this test for ambiguous cases because interpreting the results can be tricky.
Once blood tests confirm the hormone excess, an MRI of the brain pinpoints the pituitary tumor’s size and location.
Treatment Options
Surgery is the first-line treatment for most patients. The standard approach is transsphenoidal surgery, where a surgeon reaches the pituitary through the nasal passages and sinuses, avoiding the need to open the skull. Many surgeons now use an endoscope for better visualization during the procedure. For very large tumors that extend beyond the pituitary’s bony enclosure, an approach through the skull may be necessary.
When surgery doesn’t fully remove the tumor, or when someone isn’t a candidate for surgery, medications become the next step. The most commonly used drugs are somatostatin analogs, which mimic a natural brain chemical that tells the pituitary to stop releasing growth hormone. These medications also act directly on the liver to reduce IGF-1 production.
A second option is a growth hormone receptor blocker that works at the liver level, preventing growth hormone from triggering IGF-1 production. This approach normalizes IGF-1 in up to 97% of patients after a year. Dopamine-targeting drugs are a third option, though they work in only a minority of patients and carry more side effects.
Radiation therapy is generally reserved for cases where surgery and medication haven’t achieved full control. It can take months to years for radiation to bring hormone levels down, so patients typically stay on medication in the interim.
Why Early Diagnosis Matters
The 5.5-year average delay between first symptoms and diagnosis isn’t just a medical curiosity. Longer delays are directly associated with higher rates of complications and increased mortality. Many of the cardiovascular and metabolic changes that develop during those undiagnosed years are difficult to fully reverse. Bone and facial changes are permanent, though soft tissue swelling and symptoms like joint pain and sweating often improve once hormone levels are brought under control.
If you’ve noticed gradual changes in your hand or foot size, facial appearance, or unexplained joint pain combined with excessive sweating, bringing these up with a doctor and requesting an IGF-1 blood test is the fastest path to an answer. The test is simple, widely available, and can either rule out the condition or set diagnosis in motion.